Synthesis and biological evaluation of novel sinomenine derivatives as anti-inflammatory agents. 2012

Peng Teng, and Hai-Liang Liu, and Lei Zhang, and Li-Li Feng, and Yue Huai, and Zhang-Shuang Deng, and Yang Sun, and Qiang Xu, and Jian-Xin Li
State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210093, PR China.

Sinomenine (1) is clinically available for the treatment of rheumatoid arthritis (RA), however, its efficacy is quite weak. In the present study, a library of novel sinomenine-based homodimers and monomers through variable-length linkers were designed and synthesized, and their bioactivities were evaluated using RAW264.7 cells and mice. Among the compounds, 2f and 3b possessed much more potent inhibitory effects on the production of nitric oxide (NO), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) than 1. Preliminary mechanism investigation revealed that 3b inhibited nuclear factor-κB (NF-κB) signaling pathway specifically, 2f suppressed both NF-κB and mitogen-activated protein kinase (MAPK) cascades. Moreover, 3b and 2f significantly alleviated the lipopolysaccharide (LPS)-induced mortality. These two compounds might serve as valuable candidates for anti-inflammatory drug discovery.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009019 Morphinans Compounds based on a partially saturated iminoethanophenanthrene, which can be described as ethylimino-bridged benzo-decahydronaphthalenes. They include some of the OPIOIDS found in PAPAVER that are used as ANALGESICS. Morphinan
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D012772 Shock, Septic Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. Endotoxin Shock,Septic Shock,Shock, Endotoxic,Shock, Toxic,Toxic Shock,Toxic Shock Syndrome,Endotoxin Shocks,Shock Syndrome, Toxic,Shock, Endotoxin,Shocks, Endotoxin,Toxic Shock Syndromes

Related Publications

Peng Teng, and Hai-Liang Liu, and Lei Zhang, and Li-Li Feng, and Yue Huai, and Zhang-Shuang Deng, and Yang Sun, and Qiang Xu, and Jian-Xin Li
October 2022, RSC advances,
Peng Teng, and Hai-Liang Liu, and Lei Zhang, and Li-Li Feng, and Yue Huai, and Zhang-Shuang Deng, and Yang Sun, and Qiang Xu, and Jian-Xin Li
January 2014, Medicinal chemistry (Shariqah (United Arab Emirates)),
Peng Teng, and Hai-Liang Liu, and Lei Zhang, and Li-Li Feng, and Yue Huai, and Zhang-Shuang Deng, and Yang Sun, and Qiang Xu, and Jian-Xin Li
June 2016, Chemical & pharmaceutical bulletin,
Peng Teng, and Hai-Liang Liu, and Lei Zhang, and Li-Li Feng, and Yue Huai, and Zhang-Shuang Deng, and Yang Sun, and Qiang Xu, and Jian-Xin Li
March 2009, Medicinal chemistry (Shariqah (United Arab Emirates)),
Peng Teng, and Hai-Liang Liu, and Lei Zhang, and Li-Li Feng, and Yue Huai, and Zhang-Shuang Deng, and Yang Sun, and Qiang Xu, and Jian-Xin Li
June 2013, European journal of medicinal chemistry,
Peng Teng, and Hai-Liang Liu, and Lei Zhang, and Li-Li Feng, and Yue Huai, and Zhang-Shuang Deng, and Yang Sun, and Qiang Xu, and Jian-Xin Li
June 2015, Bioorganic & medicinal chemistry letters,
Peng Teng, and Hai-Liang Liu, and Lei Zhang, and Li-Li Feng, and Yue Huai, and Zhang-Shuang Deng, and Yang Sun, and Qiang Xu, and Jian-Xin Li
June 2012, Archives of pharmacal research,
Peng Teng, and Hai-Liang Liu, and Lei Zhang, and Li-Li Feng, and Yue Huai, and Zhang-Shuang Deng, and Yang Sun, and Qiang Xu, and Jian-Xin Li
August 2006, Bioorganic & medicinal chemistry,
Peng Teng, and Hai-Liang Liu, and Lei Zhang, and Li-Li Feng, and Yue Huai, and Zhang-Shuang Deng, and Yang Sun, and Qiang Xu, and Jian-Xin Li
September 2014, Fitoterapia,
Peng Teng, and Hai-Liang Liu, and Lei Zhang, and Li-Li Feng, and Yue Huai, and Zhang-Shuang Deng, and Yang Sun, and Qiang Xu, and Jian-Xin Li
April 2014, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society,
Copied contents to your clipboard!